Application 078612
- Type
- ANDA
- Sponsor
- BARR LABS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ARIPIPRAZOLE | ARIPIPRAZOLE | TABLET, ORALLY DISINTEGRATING; ORAL | 10MG | No | No |
| 002 | ARIPIPRAZOLE | ARIPIPRAZOLE | TABLET, ORALLY DISINTEGRATING; ORAL | 15MG | No | No |
| 003 | ARIPIPRAZOLE | ARIPIPRAZOLE | TABLET, ORALLY DISINTEGRATING; ORAL | 20MG | No | No |
| 004 | ARIPIPRAZOLE | ARIPIPRAZOLE | TABLET; ORALLY DISINTEGRATING | 30MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ARIPIPRAZOLE | ARIPIPRAZOLE | Camber Pharmaceuticals, Inc. | 3718e585-06b9-40fd-a3eb-18b6497a4235 | 2017-08-08 | Boxed warning, Warnings, Adverse reactions | ARIPIPRAZOLE ARIPIPRAZOLE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.